321 research outputs found

    Towards Bias Correction of FedAvg over Nonuniform and Time-Varying Communications

    Full text link
    Federated learning (FL) is a decentralized learning framework wherein a parameter server (PS) and a collection of clients collaboratively train a model via minimizing a global objective. Communication bandwidth is a scarce resource; in each round, the PS aggregates the updates from a subset of clients only. In this paper, we focus on non-convex minimization that is vulnerable to non-uniform and time-varying communication failures between the PS and the clients. Specifically, in each round tt, the link between the PS and client ii is active with probability pitp_i^t, which is unknown\textit{unknown} to both the PS and the clients. This arises when the channel conditions are heterogeneous across clients and are changing over time. We show that when the pitp_i^t's are not uniform, Federated Average\textit{Federated Average} (FedAvg) -- the most widely adopted FL algorithm -- fails to minimize the global objective. Observing this, we propose Federated Postponed Broadcast\textit{Federated Postponed Broadcast} (FedPBC) which is a simple variant of FedAvg. It differs from FedAvg in that the PS postpones broadcasting the global model till the end of each round. We show that FedPBC converges to a stationary point of the original objective. The introduced staleness is mild and there is no noticeable slowdown. Both theoretical analysis and numerical results are provided. On the technical front, postponing the global model broadcasts enables implicit gossiping among the clients with active links at round tt. Despite pitp_i^t's are time-varying, we are able to bound the perturbation of the global model dynamics via the techniques of controlling the gossip-type information mixing errors

    Graduate Student Voices

    Get PDF
    Building on previous events in this series, especially our conversation on inclusive mentoring, this panel will feature perspectives from USU graduate student leaders from across the university. Discussion will explore pressing issues in the graduate student experience through an intersectional lens and explore graduate students’ work as scholars, teachers, researchers, learners, activists, and more. Fellow graduate students, faculty, and staff will benefit from hearing this conversation, and will leave motivated to create a more inclusive and supported graduate student community at USU. Readings, resources, and campus connections to groups like the Graduate Students of Color Association, Black Student Union, Inclusion Center, and more will be shared with attendees.https://digitalcommons.usu.edu/inter_inclusion/1004/thumbnail.jp

    Hypermethylation of SOX2 Promoter in Endometrial Carcinogenesis

    Get PDF
    This paper aimed at investigating the expression and methylation profiles of SOX2, a gene coding for the stem cell-related transcription factor SOX2, in endometrial carcinomas. By methylation-specific polymerase chain reaction (MS-PCR), the methylation status of SOX2 promoter region in 72 endometrial carcinomas and 12 normal endometrial samples was examined. Methylated allele was found in 37.5% (27/72) of endometrial carcinomas but only in 8.3% (1/12) of normal endometrial, significantly more frequent in cancers (P = .0472). SOX2 mRNA level was significantly reduced in endometrial carcinoma compared with nonneoplastic endometrium (P = .045). A significant correlation between SOX2 mRNA expression and hypermethylation of SOX2 was found (P = .024). Hypermethylation of SOX2 tended to be more frequently found in type II serous or clear cell adenocarcinoma. SOX2 methylation was also significantly correlated with shorter survival of patients (P = .046). In conclusion, epigenetic mechanisms may play a crucial role on the transcriptional regulation of SOX2 and loss of SOX2 expression may be related to endometrial carcinogenesis

    Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancers

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>FBI-1 (factor that binds to the inducer of short transcripts of human immunodeficiency virus-1) is a member of the POK (POZ and Kruppel) family of transcription factors and play important roles in cellular differentiation and oncogenesis. Recent evidence suggests that FBI-1 is expressed at high levels in a subset of human lymphomas and some epithelial solid tumors. However, the function of FBI-1 in human ovarian cancers remains elusive.</p> <p>Results</p> <p>In this study, we investigated the role of FBI-1 in human ovarian cancers, in particularly, its function in cancer cell invasion via modulating membrane type 1-matrix metalloproteinase (MT1-MMP). Significantly higher FBI-1 protein and mRNA expression levels were demonstrated in ovarian cancers samples and cell lines compared with borderline tumors and benign cystadenomas. Increased FBI-1 mRNA expression was correlated significantly with gene amplification (P = 0.037). Moreover, higher FBI-1 expression was found in metastatic foci (P = 0.036) and malignant ascites (P = 0.021), and was significantly associated with advanced stage (P = 0.012), shorter overall survival (P = 0.032) and disease-free survival (P = 0.016). <it>In vitro</it>, overexpressed FBI-1 significantly enhanced cell migration and invasion both in OVCA 420 and SKOV-3 ovarian carcinoma cells, irrespective of <it>p53 </it>status, accompanied with elevated expression of MT1-MMP, but not MMP-2 or TIMP-2. Moreover, knockdown of MT1-MMP abolished FBI-1-mediated cell migration and invasion. Conversely, stable knockdown of FBI-1 remarkably reduced the motility of these cells with decreased expression of MT1-MMP. Promoter assay and chromatin immunoprecipitation study indicated that FBI-1 could directly interact with the promoter spanning ~600bp of the 5'-flanking sequence of MT1-MMP and enhanced its expression in a dose-dependent manner. Furthermore, stable knockdown and ectopic expression of FBI-1 decreased and increased cell proliferation respectively in OVCA 420, but not in the p53 null SKOV-3 cells.</p> <p>Conclusions</p> <p>Our results suggested an important role of FBI-1 in ovarian cancer cell proliferation, cell mobility, and invasiveness, and that FBI-1 can be a potential target of chemotherapy.</p

    Origin and Control of OFF-State Leakage Current in GaN-on-Si Vertical Diodes

    Get PDF
    Conventional GaN vertical devices, though promising for high-power applications, need expensive GaN substrates. Recently, low-cost GaN-on-Si vertical diodes have been demonstrated for the first time. This paper presents a systematic study to understand and control the OFF-state leakage current in the GaN-on-Si vertical diodes. Various leakage sources were investigated and separated, including leakage through the bulk drift region, passivation layer, etch sidewall, and transition layers. To suppress the leakage along the etch sidewall, an advanced edge termination technology has been developed by combining plasma treatment, tetramethylammonium hydroxide wet etching, and ion implantation. With this advanced edge termination technology, an OFF-state leakage current similar to Si, SiC, and GaN lateral devices has been achieved in the GaN-on-Si vertical diodes with over 300 V breakdown voltage and 2.9-MV/cm peak electric field. The origin of the remaining OFF-state leakage current can be explained by a combination of electron tunneling at the p-GaN/drift-layer interface and carrier hopping between dislocation traps. The low leakage current achieved in these devices demonstrates the great potential of the GaN-on-Si vertical device as a new low-cost candidate for high-performance power electronics

    The ADIPS pilot national diabetes in pregnancy benchmarking programme

    Get PDF
    Background: To test the feasibility of benchmarking the care of women with pregnancies complicated by hyperglycaemia. Methods: A retrospective audit of volunteer diabetes services in Australia and New Zealand involving singleton pregnancies resulting in live births between 2014 and 2020. Ranges are shown and compared across services. Results: The audit included 10,144 pregnancies (gestational diabetes mellitus (GDM) = 8696; type 1 diabetes (T1D) = 435; type 2 diabetes (T2D) = 1013) from 11 diabetes services. Among women with GDM, diet alone was used in 39.4% (ranging among centres from 28.8-57.3%), metformin alone in 18.8% (0.4-43.7%), and metformin and insulin in 10.1% (1.5-23.4%); when compared between sites, all p 6.5% (48 mmol/mol)), 78.4% and 54.6%, respectively (p < 0.001). Conclusion: Management of maternal hyperglycaemia and pregnancy outcomes varied significantly. The maintenance and extension of this benchmarking service provides opportunities to identify policy and clinical approaches to improve pregnancy outcomes among women with hyperglycaemia in pregnancy
    corecore